HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.

Abstract
The aim of the present study was to determine whether alterations in 5-hydroxytryptamine (5-HT)(1A) receptors would be found in knockout mice lacking the serotonin transporter (5-HTT). Hypothermic and neuroendocrine responses to the 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetraline (8-OH-DPAT) were used to examine the function of 5-HT(1A) receptors. Initial studies evaluated the dose-response and time course of 8-OH-DPAT-induced hypothermia and hormone secretion in normal CD-1 mice (the background strain of the 5-HTT knockout mice). 8-OH-DPAT dose-dependently produced hypothermic responses that peaked at 20 min postinjection. 8-OH-DPAT-induced hypothermia was blocked by the 5-HT(1A) antagonist WAY-100635. 8-OH-DPAT dose-dependently increased the concentrations of plasma oxytocin, corticotropin, and corticosterone. In the 5-HTT knockout (-/-) mice, the hypothermic response to 8-OH-DPAT (0.1 mg/kg s.c.) was completely abolished. Furthermore, 5-HTT-/- mice had significantly attenuated plasma oxytocin and corticosterone responses to 8-OH-DPAT. No significant changes in the hypothermic or hormonal responses to 8-OH-DPAT were observed in heterozygous (5-HTT+/-) mice. [(3)H]8-OH-DPAT- and [(125)I]MPPI [4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-iodobenzamido]ethyl] pip erazine]-binding sites in the hypothalamus and [(125)I]MPPI-binding sites in the dorsal raphe were significantly decreased in 5-HTT-/- mice. The results indicate that lack of the 5-HTT is associated with a functional desensitization of 5-HT(1A) receptor responses to 8-OH-DPAT, which may be a consequence, at least in part, of the decrease in density of 5-HT(1A) receptors in the hypothalamus and dorsal raphe of 5-HTT-/- mice.
AuthorsQ Li, C Wichems, A Heils, L D Van De Kar, K P Lesch, D L Murphy
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 291 Issue 3 Pg. 999-1007 (Dec 1999) ISSN: 0022-3565 [Print] United States
PMID10565817 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aminopyridines
  • Carrier Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Piperazines
  • Pyridines
  • Receptors, Serotonin
  • Receptors, Serotonin, 5-HT1
  • Serotonin Antagonists
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Receptor Agonists
  • Slc6a4 protein, mouse
  • 4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine
  • Serotonin
  • Oxytocin
  • N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
  • 8-Hydroxy-2-(di-n-propylamino)tetralin
  • Adrenocorticotropic Hormone
  • Corticosterone
Topics
  • 8-Hydroxy-2-(di-n-propylamino)tetralin (pharmacology)
  • Adrenocorticotropic Hormone (blood)
  • Aminopyridines (pharmacokinetics)
  • Animals
  • Autoradiography
  • Body Temperature (drug effects)
  • Carrier Proteins (genetics, metabolism)
  • Corticosterone (blood)
  • Dose-Response Relationship, Drug
  • Hypothalamus (drug effects, metabolism)
  • Membrane Glycoproteins (genetics, metabolism)
  • Membrane Transport Proteins
  • Mice
  • Mice, Knockout
  • Nerve Tissue Proteins
  • Neurosecretory Systems (drug effects, metabolism)
  • Oxytocin (blood)
  • Piperazines (pharmacokinetics, pharmacology)
  • Pyridines (pharmacology)
  • Raphe Nuclei (drug effects, metabolism)
  • Receptors, Serotonin (drug effects, genetics)
  • Receptors, Serotonin, 5-HT1
  • Serotonin (metabolism)
  • Serotonin Antagonists (pharmacology)
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Receptor Agonists (pharmacology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: